For the first time in over a decade, a significant shift in America’s obesity trends has emerged, signaling hope for better public health outcomes. A recent study tracking Body Mass Index (BMI) data reveals a slight but notable decrease in average BMI across the U.S. in 2023, offering a glimmer of optimism in the ongoing battle against obesity.
Researchers, utilizing a combination of medical and insurance claims data, as well as electronic health records, analyzed trends over a ten-year period. The findings show a steady rise in BMI from 29.65 in 2013 to 30.23 in 2021, a period that coincided with the height of the COVID-19 pandemic when many Americans experienced lifestyle disruptions. However, the trend began to plateau in 2022 at a BMI of 39.24, and in 2023, the first drop in BMI in over a decade was recorded, reaching 30.21.
While the reduction of 0.03 may seem modest, health experts are hopeful that this signals a larger, positive trend. “To hear that obesity prevalence is decreasing or at least flattening is great news,” said Dr. Andrea Coviello, Director of the UNC Weight Management Program. “It is something that has affected so many people and their health in so many ways, and it’s encouraging to see signs of improvement.”
Despite the promising results, Dr. Coviello notes that the study, which relied on estimates from insurance and health data, might not fully capture the broader picture. “This study primarily includes people who are actively engaged in healthcare, which may exclude those who are less likely to seek regular care—those most impacted by obesity,” she explained. Dr. Coviello emphasized the need for a more comprehensive study that includes a broader range of the population to provide a clearer understanding of the national health trends.
The focus, according to Coviello, should now shift toward increasing engagement in weight management across the entire population. “We need more efforts to encourage healthy lifestyle changes, better nutrition, more physical activity, and less stress,” she said. These factors can not only help individuals manage their weight but also reduce the risk of obesity-related diseases such as diabetes, hypertension, and cardiovascular conditions.
The study also explored the increasing use of weight loss medications, such as GLP-1s, a class of drugs that have shown promise in clinical trials for weight reduction. The South reported the highest reduction in BMI and the greatest usage of weight loss medications. However, Dr. Coviello pointed out that only 6% of the population used these medications, and while this group saw a 1% decrease in obesity prevalence, it remains unclear how much of this reduction is attributable to the use of weight loss drugs.
“GLP-1s are showing potential, but more time is needed to understand their full impact,” Coviello said. The expansion of Medicaid coverage for these medications in North Carolina earlier this year has already made a noticeable difference. “The ability to offer GLP-1s to people on Medicaid has been transformational for many of my patients,” Coviello noted.
In addition to medical interventions, Dr. Coviello believes that broader public health initiatives may be contributing to the positive shift. Campaigns from the CDC, WHO, and local health organizations are raising awareness about the importance of weight management, encouraging healthier lifestyles and preventive care.
“Many patients come to us seeking advice, not just for themselves, but because they don’t want their children to face the same challenges,” Dr. Coviello shared. This shift in mentality—towards preventative care and early intervention—could be a significant factor in the recent drop in BMI.
Read more:
- America’S Health Care Crisis: A Moral Dilemma That Demands Reform
- Best Fruits To Eat While Pregnant: A Guide For Expecting Mothers
- The 6 Best Gummy Vitamins For Adults Over 50
